Gilteritinib Fumarate | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Gilteritinib Fumarate
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Gilteritinib Fumarate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

6 API Suppliers, 1 USDMF, 1 EU WC, 1 NDC API, 5 Listed Suppliers, $ API Reference Price

6 API Suppliers
1 USDMF
1 EU WC
1 NDC API
5 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

20 Drugs in Development

20 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

4 FDF Dossiers, 1 FDA Orange Book, 1 Europe, 2 Australia

4 FDF Dossiers
1 FDA Orange Book
1 Europe
2 Australia

DIGITAL CONTENT

40 NEWS #PharmaBuzz

40 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 Finished Drug Prices, 5 Annual Reports

1 Finished Drug Prices
5 Annual Reports

MARKET PLACE

2 APIs, 1 FDF Dossiers

2 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 US Patents, 1 US Exclusivities

8 US Patents
1 US Exclusivities

$ API Ref.Price (USD/KG) : 49,603 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

8 All

01 8ASTELLAS

filter Patent Number Reset all filters

8 All

01 18969336

02 19487491

03 110786500

04 111938130

05 111938131

06 111938132

07 111938133

08 111944620

filter API Patent Reset all filters

8 All

01 1Y

02 7Blank

filter FDF Patent Reset all filters

8 All

01 7Y

02 1Blank

filter Expiration Date Reset all filters

8 All

01 12030-07-28

02 12032-11-28

03 62036-07-01

Product Main Page

01

ASTELLAS

GILTERITINIB FUMARATE

BioAsia

Not Confirmed

ASTELLAS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-07-28

GILTERITINIB FUMARATE

US Patent Number : 9487491

Drug Substance Claim :

Drug Product Claim :

Application Number : 211349

Patent Use Code : U-2456

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-07-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

ASTELLAS

GILTERITINIB FUMARATE

BioAsia

Not Confirmed

ASTELLAS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-07-01

GILTERITINIB FUMARATE

US Patent Number : 11938133

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211349

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ASTELLAS

GILTERITINIB FUMARATE

BioAsia

Not Confirmed

ASTELLAS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-07-01

GILTERITINIB FUMARATE

US Patent Number : 11944620

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211349

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

ASTELLAS

GILTERITINIB FUMARATE

BioAsia

Not Confirmed

ASTELLAS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-07-01

GILTERITINIB FUMARATE

US Patent Number : 11938130

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211349

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

ASTELLAS

GILTERITINIB FUMARATE

BioAsia

Not Confirmed

ASTELLAS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-07-01

GILTERITINIB FUMARATE

US Patent Number : 10786500

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211349

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

ASTELLAS

GILTERITINIB FUMARATE

BioAsia

Not Confirmed

ASTELLAS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-11-28

GILTERITINIB FUMARATE

US Patent Number : 8969336

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 211349

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-11-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

ASTELLAS

GILTERITINIB FUMARATE

BioAsia

Not Confirmed

ASTELLAS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-07-01

GILTERITINIB FUMARATE

US Patent Number : 11938131

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211349

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

ASTELLAS

GILTERITINIB FUMARATE

BioAsia

Not Confirmed

ASTELLAS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-07-01

GILTERITINIB FUMARATE

US Patent Number : 11938132

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211349

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!